findmyKOL
Clinical trialNCT02749968CompletedPhase 2Interventional

Intercostal Liposomal Bupivacaine for the Management of Blunt Chest Wall Trauma

SponsorUniversity of CincinnatiEnrollment100Blunt Chest Wall TraumaRib FractureSternal Fracture
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a study of liposomal bupivacaine for pain control in patients with blunt chest wall trauma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Michael D Goodman, MD

    Department of Surgery, University of Cincinnati

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Cincinnati Medical Center

    Cincinnati, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Sodium chloride →Liposomal bupivacaine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Mar 2018
Primary completion
1 Jan 2021
Completion
1 Jan 2021
Last update posted
4 Apr 2022
Registered enrollment
100
Registry id
NCT02749968
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.